Benefits with incretin-targeted therapies in T2DM

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1596, 2007-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Variable results for targeted insulin treatment in T2DM

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

HER2 Targeted Therapies for Cancer and the Gastrointestinal Tract

Current Drug Targets, Vol. 10, Iss. 6, 2009-06 ,pp. : 537-542

Bentham Science Publishers

Access to resources Recommend Favorite

Incretin-based therapies for type 2 diabetes mellitus: a review of direct comparisons of efficacy, safety and patient satisfaction

By Russell Sheldon

International Journal of Clinical Pharmacy, Vol. 35, Iss. 2, 2013-04 ,pp. : 159-172

Springer Publishing Company

Access to resources Recommend Favorite

New Approaches to Treating Type 2 Diabetes Mellitus in the Elderly: Role of Incretin Therapies

By Abbatecola Angela M.

Drugs & Aging, Vol. 25, Iss. 11, 2008-01 ,pp. : 913-925

Adis International

Access to resources Recommend Favorite

Current and Future Treatment Directions in T2DM

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite